NIAID Strategic Plan Details Covid-19 Research Priorities
Research is needed to improve our understanding of the virus and how it causes covid-19, and to develop strategies to mitigate illness and death.
Read MorePosted by | May 4, 2020 | Allergy & Autoimmune, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Research is needed to improve our understanding of the virus and how it causes covid-19, and to develop strategies to mitigate illness and death.
Read MorePosted by | Apr 22, 2020 | Allergy & Autoimmune, Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases, Serology Instrumentation |
The question of when we can return to work and resume our normal activities is one of the most critical issues facing our nation.
Read MorePosted by | Apr 21, 2020 | Cancer, Cardiovascular, Computing Systems, Gastrointestinal Infections, Information Technology, Leukemia, Middleware & Software, Molecular Diagnostics |
A noninvasive blood test may provide a ‘crystal ball’ for early detection of infections, leading to increased cure rates among pediatric leukemia patients.
Read MorePosted by | Apr 15, 2020 | Allergy & Autoimmune, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
No instrumentation or trained personnel would be needed to administer the test or to read the results.
Read MorePosted by Steve Halasey | Mar 31, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Abbott’s new test is the fastest available molecular point-of-care test for the diagnosis of covid-19, delivering positive results in as little as 5 minutes and negative results in 13 minutes.
Read More